Loading insider details...
Beta
Latest Form 4 (Jul 21, 2026): Grant/Award of 136 ARTL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 21, 2026 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/Award | 136 | n/a |
| Jun 9, 2026 | SUTRO BIOPHARMA, INC. (STRO) | Grant/Award | 10,000 | n/a |
| Feb 2, 2026 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/Award | 292 | n/a |
| Dec 29, 2025 | SUTRO BIOPHARMA, INC. (STRO) | Grant/Award | 1,500 | n/a |
| Oct 31, 2025 | ARTELO BIOSCIENCES, INC. (ARTL) | Conversion | 38,346 | n/a |
| Oct 16, 2025 | SUTRO BIOPHARMA, INC. (STRO) | Purchase | 50,000 | $40.0K |
| Jun 10, 2025 | SUTRO BIOPHARMA, INC. (STRO) | Grant/Award | 50,000 | n/a |
| Dec 23, 2024 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/Award | 1,750 | n/a |
| Dec 3, 2024 | HALOZYME THERAPEUTICS, INC. (HALO) | Gift | 10,470 | n/a |
| Jun 10, 2024 | SUTRO BIOPHARMA, INC. (STRO) | Grant/Award | 35,000 | n/a |